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ABSTRACT
Purpose: In 1965, the Food and Drug Administration (FDA) approved the use of ipecac for over-the-counter sale. For years,
ipecac remained on the list of “must have” items for households with small children. Typically, ipecac was used to administer an
emetic quickly before reaching the emergency room or to prevent the patient from having to be referred to a medical facility. In
2004, new ipecac guidelines were published stating that the routine stocking and use of Ipecac would no longer be
recommended. The new guidelines would change what had been accepted for decades. Though Ipecac is no longer suggested
for home use, the possibility may still exist that for particular populations, it may still be necessary. The decision is left to the
individuals’ healthcare provider or poison control center, as the recommendation states that the experts would be able to the
make the best decision in determining a need to administer ipecac. The recommendation reinforces the need for healthcare
providers to use current clinical guidelines and their own clinical judgment in providing advice to patients. The access to care
problems we face will make it imperative that all healthcare providers keep up-to-date on public health issues. In this way, we
can help our patients to become better health advocates.
INTRODUCTION
In 2007, approximately 2.4 million people (more than half under the age of five) swallowed or had contact with a poisonous
substance. The American Association of Poison Control Centers’ (AAPCC) website identifies a poison exposure as any incident
that occurs when a person swallows, breathes, touches, or has eye contact with something that can cause sickness or death.
Using data gathered from the Toxic Exposure Surveillance System (TESS), it was noted that most of the poison exposures
happen at home and involve children between eight months and six years of age.1
In a poisoning episode, the outcome depends on the amount of “poison” absorbed by the body. A poisoning exposure is
considered dose related, as in theory too much of anything can be dangerous. Since absorption determines outcome, the time
from a poison exposure to delivery of an emetic and then the actual emesis is important. Unfortunately, determination of the
absorption rate can depend on a number of factors such as the amount of poison consumed, foods that were previously
ingested, or hyperperistalsis.2 Garrison et al stated that a timely administered emetic would be 30 minutes or less from the
poison exposure time, and a timely emesis would be 60 minutes or less post exposure.3
According to the Institute of Medicine (1990), “Clinical practice guidelines are systematically developed statements to assist
practitioner and patient decisions about appropriate health care for specific clinical circumstances.”4 The term assist ensures that
clinical judgment is never abandoned in these guidelines. All healthcare providers must to be able to use anticipatory guidance
and current guidelines in advising patients. The challenges accessing health care today will require all healthcare providers to
assist patients in becoming their own personal health advocates. The current viewpoint regarding ipecac for its use in suspected
poisonings, including past and present recommendations, will be the focus of this article.
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BACKGROUND
In 1965, the Food and Drug Administration (FDA) approved ipecac syrup for over-the-counter (OTC) sale.5 However, though
ipecac was moved to OTC status, it was not until a clinical trial was published in 1969 that its general acceptance began. The
trial compared ipecac to gastric lavage (pumping the stomach), noting that ipecac was a more effective overall method for
removal of poisons. It was also noted that neither method removed more than small amounts of poisons or was consistent in
removing poisons. Regardless, the trial set in motion the recommended use of ipecac by Poison Centers and pediatrician
offices.6 Throughout the next two decades, ipecac syrup was placed in first aid kits and remained on the “must have list” of items
for households with new babies or small children. This recommendation asked parents to keep a bottle of ipecac at home and in
the diaper bag to cover any accidental poisoning incidents while away. If a mishap occurred, one was to call the local Poison
Control Center to be advised when or if ipecac should be used.7 The original intent for ipecac was to use it only after safety
practices to prevent injury had been compromised.
Traditionally, ipecac was used in two ways: 1) to begin the gastric emptying process before arrival at the emergency department,
or 2) to prevent patients from requiring referral to a medical facility at all. The poison center staff would perform follow-up
telephone calls in instances where ipecac was given at home to document the progress of patient or the outcome of the
incident.7-8
Though various studies contribute information to the benefits and risks of ipecac as a quick emetic, many were quick to note the
lack of research to support the 1965 recommendation. Some studies showed ipecac to be ineffective and often unpredictable for
removal of stomach contents, while other studies touted it as effective. 2,3, 6-13 Though the acknowledgement of ipecac’s
deficiencies were noted, it was maintained that ipecac was still the best home choice being used.2,3, 6-13 Corby et al. gave
possible reasons why there was discrepancy among researchers. They suggested that studies on emetics contained many
complicated variables, and there was an overall lack of controlled research. Any or all of these differences could bring about a
variety of conclusions.2 As studies were being examined, the consensus was that there was insufficient research available on
ipecac use.
WHAT IS IPECAC?
Ipecac comes from the Cephaelis Ipecacuanha plant, and having no brand name, is known only by ipecac syrup (ipecac), its
generic name. Ipecac is classified as an antidote or emetic. An emetic is a substance used to induce vomiting, working by
irritating the lining of the stomach and stimulating the vomiting center of the brain. Ipecac is usually dispensed in one-ounce
brown plastic bottles, and when recommended for use, the general dose for a child 1 to 12 years old is 15 ml. followed by 120240 ml of water. The vomitus is to be saved to determine ipecac’s effectiveness in removing the stomach contents.6,14-15
A bottle labeled as being ipecac fluid extract or ipecac tinctures should never be used, as these dosage forms are too potent for
use. Only ipecac syrup can be considered an emetic for poison episodes.15
Labeled as an emetic, ipecac is used to cause vomiting, which it usually accomplishes; however, there can also be undesired
effects. Vomiting can be dangerous if a caustic material is swallowed. The ipecac along with the caustic material is forced back
into the esophagus causing further damage to esophageal tissues. Symptoms from ipecac use can include drowsiness, diarrhea,
or stomachache. The expected effects from ipecac make it more complicated to determine whether the side effects are from the
actual poison or the ipecac. Some of the more severe reactions can be shock, dehydration, or cardiac arrest.8,9,12-15 However,
some studies noted a total absence of even minimal cardiac changes or the presence of any other severe side effects occurring
when ipecac was given in therapeutic amounts.16,17 While the literature does document certain severe complications and even
death, such complications have been linked to continued misuse, as in Bulimia Nervosa patients or other eating disorders, and
Munchhausen by Proxy Syndrome.12,16-18 The documented misuse by certain populations has used to advocate for the removal
of ipecac from an over-the-counter drug status.6,9,12,14
OTHER EMETICS
Besides ipecac, other agents have been used for the treatment of poisoning episodes. Two of the choices were activated
charcoal and gastric lavage. The activated charcoal was used to absorb the potential poison thus preventing it from being
absorbed by the body. A notice in 1998 announced that activated charcoal was the item to be kept in the home to replace
ipecac.19 Many did not realize that ipecac had been replaced until their prenatal physician advised them. Currently, the American
Poison Control Center (APCC) site lists activated charcoal for hospital/professional use only.20
Studies have acknowledged that other methods have demonstrated better results than ipecac. However, the possibility of these
methods being used for immediate treatment is not feasible without appropriate training. 2,10The use of gastric lavage (stomach
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pumping) when compared to ipecac is generally considered more effective, but must also be done by trained personnel in an
emergency setting.20
Though ingestion of poisons for child under the age of six is a common event, the death from poisoning for this age is
uncommon. In 1940, the number of deaths was noted at 500 and by 1997; the numbers had dropped to only 25 deaths21. One
reason for the drop in deaths related to poisoning was the 1970’s introduction of childproof caps and smaller dosage packaging
of products, which are seen as main reasons for this reduction. Many newer products are formulated so that in some cases,
everyday kitchen items may be used as antidotes. Products continuously change, and with the development of less toxic
formulas, along with quick access to antidote/s and information from poison control sites, the reversal of a possible tragic event
may only be a call away.22
PRESENT STATUS
The National Capital Poison Centers website contains a chronological listing of historical information concerning ipecac. In 2003,
the U.S. Food and Drug Administration (FDA) Nonprescription Drug Advisory Council held hearings to discuss the OTC status of
ipecac. The panel advised the FDA to overturn the non- prescription drug status that ipecac has held since 1965. However, the
drug status still has not been changed as of April 20, 2009.
In 2003, the American Academy of Pediatrics (AAP) issued a policy statement regarding consumer use of ipecac. It stated it
would no longer recommend ipecac syrup for routine use to induce vomiting in accidental poisoning. The recommendation also
noted that keeping ipecac in the home was unnecessary, and recommend disposal of any stocked ipecac syrup. The AAP went
on to state that if there is a suspected poisoning; the first course of action is to always contact the poison control center for
information.22
In 2004, panel members from the American Association of Poison Control Centers, the American Academy of Clinical
Toxicology, and the American College of Medical Toxicology issued the “Guideline on the Use of Ipecac Syrup in the Out-ofHospital Management of Ingested Poisons.” The panel concluded that ipecac is rarely useful in treating childhood poisoning. The
guidelines also backed the American Academy of Pediatrics’ (AAP) recommendation that ipecac syrup should no longer be
routinely used to induce vomiting in an incidence of poisoning and to dispose of any stock on hand. The panel noted there was a
small group that could benefit from stocking ipecac (see Figure 1), but recommended the individuals’ healthcare providers and
poison control centers assist in determining need.7 The AAPCC followed the panel’s guidelines concerning ipecac use, and also
agreed with its position that activated charcoal should not be recommended for use in home poison episodes either. The panel
did not address the removal of ipecac from the OTC status. The AAPCC has noted that most pharmacies no longer stock ipecac
syrup.20
AMERICAN ASSOCIATION OF POISON CONTROL CENTERS (AAPCC)
In1958, the AAPCC was founded to promote cooperation between all poison centers in different cities and to standardize their
operations. A National Poison Prevention Week (NPPW) was established in 1961. The third week in March is now designated as
NPPW week and is used to educate and promote poison prevention. As of 2001, anyone can dial 1-800-222-1222 and connect
with the nearest poison control center anywhere in the United States. Experts on hand will answer all calls from the 64 poison
control sites throughout the country. The staff will help with your questions or provide information in a suspected case of
poisoning, 365 days a year, seven days a week, 24 hours a day, free of charge.22
The American Academy of Pediatrics (AAP) 2003 published the following statement:
… if a child is unconscious, not breathing, or having convulsions or seizures due to poison contact or ingestion, call
911 or your local emergency number immediately. If you child has been exposed to poison, and has mild or no
symptoms, call your poison control center at 1-800-222-1222. For swallowed poison, remove the item from the child,
and have the child spit out any remaining substance. The website also states to not have the child vomit and not to use
syrup of ipecac.
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Figure 1. Possible group where ipecac may be of use.
The possible group where ipecac may be of use would include:
· no contraindication of use or possibility of severe toxicity
· no alternative therapy available to decrease absorption,
· if a delay of more than 1 hour before patient could arrive at an
emergency facility
· ipecac could be administered within 30-90 minutes of ingestion.
The panel did not address removal of ipecac from OTC status
The panel did not support routine stocking of ipecac for households of
young children.
The panel gave no consensus on which homes could benefit from
stocking ipecac: an individual’s practitioners and poison control centers
should determine.
Manoguerra AS, Cobaugh DJ, et al., The Members of the Guidelines for
the Management of Poisonings Consensus. Guideline on the use of
ipecac syrup in the out-of-hospital management of ingested poisons.
Clinical Toxicology. 2005; 43(1): 1-10.
______________________________________________________________________________________________________
CONCLUSIONS
The 2004 guidelines suggesting the suspension of ipecac use for home poison episodes does not mean that there is no support
for home use of ipecac. Conclusions from many studies stated that although ipecac may not be the best option, until a better
home emetic is found, it might still be the best choice available. Ipecac is an emetic that when kept in homes, is accessed quickly
and can be utilized without training.
Healthcare professionals should always use anticipatory guidance when teaching prevention; it is the number one step in
reducing poison episodes. It is also important to keep in mind the potential toxicity and abuse of ipecac for certain risk groups.
Specific poison-related information for prevention and education can be found at the American Association of Poison Control
Centers website.
Healthcare providers must understand the possibility exists that for particular populations, ipecac may need to be present in the
home. The decision will only be resolved by using current clinical guidelines and clinical judgment to help patients become their
own health advocates. A person’s health maybe linked to many healthcare providers; the need to work together and stay
informed of current clinical guidelines will help to build a healthier community.
FUTURE RESEARCH
A poisoning episode is a common childhood occurrence. When a child encounters a poisonous substance and the need for
emesis is determined, the possibility still exists that the presence of ipecac may be of benefit when weighing the reliability of
arriving for treatment at a hospital within thirty minutes. Studies have shown that without storing ipecac at home, ipecac could not
be reliably administered in a timely manner. What role does ipecac play for populations in rural areas with limited access to
emergency treatment, reliable communication, or travel problems? Perhaps the role of ipecac still needs consideration until a
more reliable emetic can be kept in homes.

______________________________________________________________________________
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